Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.2450 (3.58%) ($8.2450 - $8.2800) on Wed. May. 31, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.75% (three month average) | RSI | 43 | Latest Price | $8.2450(3.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(27%) XLRE(26%) ARKG(24%) SDY(24%) VYM(22%) | Factors Impacting BCRX price | BCRX will decline at least -1.375% in a week (0% probabilities). VIXM(-24%) VXX(-23%) TLT(-14%) VCIT(-13%) SHY(-11%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.375% (StdDev 2.75%) | Hourly BBV | 2.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.39 | 5 Day Moving Average | $8.1(1.79%) | 10 Day Moving Average | $8.3(-0.66%) | 20 Day Moving Average | $8.39(-1.73%) | To recent high | -6.5% | To recent low | 11.8% | Market Cap | $1.455b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |